节点文献
BRDⅡ株风疹减毒活疫苗免疫持久性观察
Immunopersistent of Attenuated Live Rubella Vaccine Prepared with BRD Ⅱ Strain
【摘要】 应用BRDⅡ株26代、28代和31代风疹减毒活疫苗对风疹血凝抑制(HI)抗体阴性的551名1~6岁儿童进行了免疫效果观察。3批疫苗免局42天抗体阳转率分别为98.0%、96.8%和96.4%,抗体GMT分别为115.1、100.9和94.8,表明BRDⅡ株具有良好的免疫原性。3批疫苗的抗体GMT逐年下降,到第3年分别为34、4、36.9和31.2,但各批间差异无显著意义。免后3年,26代和28代疫苗的抗体阳性率仍保持在95%以上,而31代疫苗的抗体阳性率下降至89.2%,明显低于其它两批疫苗。
【Abstract】 551 children (aged 1~6 years) without HI antibodies to rubella were inmmunized with 3 lots of attenuated live rubella vaccines prepared with the 26th, 28th and 31th passage of BRD Ⅱ strain respectively. The HI antibody positive conversion rates of the children 42 days after being immunized with the 3 lots were 98.0%, 96. 8% and 96. 4%respectively, and the GMTs of them were 115. 1, 100.9 and 94. 8 respectively. The result showed good immunogenicity of BRDⅡ strain. The GMTs were decreased from year to year. They were 34. 4, 36. 9 and 31. 2 respectively at the 3rd year after immunization. However, no significant difference was found among the GMTs of the 3 lots. At the 3rd year,the antibody positive rates of the vaccines prepared with the 26th and 28th passage of BRD Ⅱ strain were still above 95%, but that of the vaccine prepared with the 31th passage was decreased to 89. 2 %, that was signficantly lower than those of the other 2 lots.
【Key words】 Attenuated live rubella vaccine; Antibody positive conversion rate; Immunogenicity;
- 【文献出处】 中国生物制品学杂志 ,CHINESE JOURNAL OF BIOLOGICALS , 编辑部邮箱 ,1997年04期
- 【分类号】R392
- 【被引频次】3
- 【下载频次】51